How to buy GSK shares

GSK shares have increased 0.52% from their previous closing price (1669.2p). Learn how to easily invest in GSK shares.

GSK
LSE: GSK-GBX
About two hours ago

1677.8p

+8.6p (+0.52%)

The global stock market has taken a big hit recently due to the ongoing coronavirus pandemic. While the GSK share price has also dropped, investors may see it GlaxoSmithKline shares as a safer long-term bet, especially given its history with developing vaccines. GlaxoSmithKline plc (LON:GSK) is a British pharmaceutical company based in Brentford. It is part of the FTSE 100 and helped developed the world’s first malaria vaccine in 2014.

How to buy shares in GSK

  1. Choose a platform. If you're a beginner, our share trading platform picks below can help you choose.
  2. Open your account. Provide your personal information and sign up.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GSK in this case.
  5. Research shares. The platform should provide the latest information available.
  6. Buy your shares. Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy GSK shares

Best for beginner investments

Capital at risk. T&Cs apply.
Discounts for regular investing
  • 13,000+ shares to invest in
  • Choose from over 5,000 ETFs
  • Exclusive out-of-hours trading

Best for 0% commission stocks

Finder Award
Capital at risk. Other fees apply.
Copy picks from top traders
  • Commission-free stock trades
  • Receive dividend payments
  • Invest in fractional shares

Best for US shares

Finder Award
Capital at risk. T&Cs apply.
Try Plus free for 3 months
  • 0% commission on trades
  • Choose from 3000+ stocks
  • Real-time live pricing

Fees calculator for buying GSK shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

100
Platform Finder score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.39/5 ★★★★★
£0 $50 £1,694.62
Go to siteCapital at risk
IG Share Dealing logo
4.07/5 ★★★★★
£0 £0 £1,694.19
Go to siteCapital at risk
XTB logo
4.3/5 ★★★★★
£0 £0 £1,686.19
Go to siteCapital at risk
CMC Invest share dealing account logo
4.38/5 ★★★★★
£0 £0 £1,686.19
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2/5 ★★★★★
£0 £1 £1,698.14
Go to siteCapital at risk
InvestEngine logo
4.34/5 ★★★★★
0% - 0.25% £100 £1,686.19
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in GSK

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including GSK), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

GSK is a major part of the London stock exchange, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

IconFund5-year performanceLink to invest
HSBC iconHSBC FTSE 100 (HUKX)22.16%Invest with IGCapital at risk
Vanguard iconVanguard FTSE 100 (VUKE)22.05%Capital at risk
iShares iconiShares Core FTSE 100 (CUKX)21.95%Invest with eToroCapital at risk
Xtrackers iconXtrackers FTSE 100 (XDUK)21.88%Invest with IGCapital at risk
Lyxor iconLyxor FTSE 100 (100D)21.18%Invest with IGCapital at risk
Invesco iconInvesco FTSE 100 (S100)21.09%Invest with IGCapital at risk

Is it a good time to buy GSK stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

Use our graph to track the performance of GSK stocks over time.

Share price volatility

Over the last 12 months, GSK's shares have ranged in value from as little as 1276.335 up to 1682.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while GSK's is 0.257. This would suggest that GSK's shares are less volatile than average (for this exchange).

Historical closes compared with the last close of 1677.8

1 week (2024-02-12)2.19%
1 month (2024-01-18)7.30%
3 months (2023-11-19)19.16%
6 months (2023-08-17)24.37%
1 year (2023-02-16)13.04%
2 years (2022-02-13)6.78%
3 years (2021-02-18)38.07%
5 years (2019-02-19)6.59%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in GSK shares
Finder Award
  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is GSK under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the GSK P/E ratio, PEG ratio and EBITDA

GSK's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, GSK shares trade at around 14x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United Kingdom stock market as of 09 November, 2023 (10). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, GSK's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.

GSK's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2925. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into GSK's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider GSK's PEG ratio in relation to those of similar companies.

GSK's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping £10.4 billion.

The EBITDA is a measure of a GSK's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Catalent shares

    Ever wondered how to buy shares in Catalent? We explain how and compare a range of providers that can give you access to many brands, including Catalent.

  • How to buy Canopy Growth shares

    Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.

  • How to buy Green Thumb Industries shares

    Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.

  • How to buy Curaleaf Holdings shares

    Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.

  • How to buy Bionano Genomics shares

    Ever wondered how to buy shares in Bionano Genomics? We explain how and compare a range of providers that can give you access to many brands, including Bionano Genomics.

  • How to buy Genesis Healthcare shares

    Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.

  • How to buy Sundial Growers shares

    Ever wondered how to buy shares in Sundial Growers? We explain how and compare a range of providers that can give you access to many brands, including Sundial Growers.

  • How to buy Sensyne Health shares

    Ever wondered how to buy shares in Sensyne Health? We explain how and compare a range of providers that can give you access to many brands, including Sensyne Health.

  • How to buy Advanced Oncotherapy shares

    Ever wondered how to buy shares in Advanced Oncotherapy? We explain how and compare a range of providers that can give you access to many brands, including Advanced Oncotherapy.

  • How to buy Allergy Therapeutics shares

    Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.

Go to site